Semaglutide and the risk of adverse liver outcomes in patients with nonalcoholic fatty liver disease and type 2 diabetes: a multi-institutional cohort study
Hepatology International · 2025
DOI: 10.1007/s12072-024-10752-9 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Hepatology International, 2025. Verfasst von Chia-Chih Kuo und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Chi Mei Medical Center, Tainan, Taiwan. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Non-alcoholic Fatty Liver Disease, Glucagon-Like Peptides, Hypoglycemic Agents. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 24 Literaturangaben.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Internal Medicine, Chi Mei Medical Center, Tainan, Taiwan.
- Department of Physical Medicine and Rehabilitation, Chi Mei Medical Center, Tainan, Taiwan.
- Department of Internal Medicine, Chi Mei Medical Center, Tainan, Taiwan. kht@mail.chimei.org.tw.
- School of Medicine, College of Medicine, National Sun Yat-Sen University, Kaohsiung, Taiwan. kht@mail.chimei.org.tw.
- Department of Intensive Care Medicine, Chi Mei Medical Center, Tainan, Taiwan. dtmed141@gmail.com.
- School of Medicine, College of Medicine, National Sun Yat-Sen University, Kaohsiung, Taiwan. dtmed141@gmail.com.
Zitieren
APA
Kuo, C. C., Chuang, M. H., Li, C. H., Huang, P. Y., Kuo, H. T., & Lai, C. C. (2025). Semaglutide and the risk of adverse liver outcomes in patients with nonalcoholic fatty liver disease and type 2 diabetes: a multi-institutional cohort study. Hepatology International. https://doi.org/10.1007/s12072-024-10752-9
Vancouver
Kuo CC, Chuang MH, Li CH, Huang PY, Kuo HT, Lai CC. Semaglutide and the risk of adverse liver outcomes in patients with nonalcoholic fatty liver disease and type 2 diabetes: a multi-institutional cohort study. Hepatology International. 2025. doi:10.1007/s12072-024-10752-9
BibTeX
@article{Kuo2025,
author = {Kuo, Chia-Chih and Chuang, Min-Hsiang and Li, Chun-Hsien and Huang, Po-Yu and Kuo, Hsing-Tao and Lai, Chih-Cheng},
title = {Semaglutide and the risk of adverse liver outcomes in patients with nonalcoholic fatty liver disease and type 2 diabetes: a multi-institutional cohort study},
journal = {Hepatology International},
year = {2025},
doi = {10.1007/s12072-024-10752-9}
}
EUVIMED